Physician profile
Harsh Dangaria
NPI 1861789992
$18,416.41
in general payments reported to CMS, 2019-2025
49 companies · $865 in 2025
The $865 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,402 · 2021: $874 · 2022: $2,012 · 2023: $564 · 2024: $882 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,310.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $9,881.57 | 2019-2022 | |
| Boston Scientific Corporation | $1,903.45 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $1,122.06 | 2022-2024 | Ha Minuteman G3-R |
| Abbott Laboratories | $757.71 | 2019-2025 | Eterna, Proclaim |
| Vertos Medical, INC. | $483.07 | 2021-2024 | Mild Device Kit |
| Nevro Corp. | $460.83 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $435.52 | 2019-2025 | Relistor |
| Abbvie INC. | $347.06 | 2021-2025 | Ubrelvy, Qulipta |
| Medtronic, INC. | $325.92 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Curonix LLC | $266.09 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Flowonix Medical Incorporated | $247.75 | 2019-2020 | |
| Grt US Holding, INC. | $240.24 | 2022 | |
| Tersera Therapeutics LLC | $191.98 | 2019-2025 | Prialt |
| Biodelivery Sciences International, INC. | $120.36 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $120.35 | 2019-2025 | Xtampza |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsh Dangaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.